Stock listing

A2N5RY Stock Price, News, Filings & Events — Guardant Health, Inc.

Selected listing: A2N5RY · LSX · EUR · DE

A2N5RY:LSX represents Guardant Health, Inc., a company focused on precision oncology through its innovative blood tests for cancer detection and treatment monitoring. Recently, Guardant Health has been involved in advancing its product offerings and expanding its market presence, with updates on clinical trials and partnerships that enhance its position in the healthcare sector. Investors can find relevant news, regulatory filings, and upcoming events that may impact the company's performance and strategic direction. The overall market context reflects a growing interest in cancer diagnostics and personalized medicine, which could influence Guardant Health's future growth.

A2N5RY:LSXEURDEUpdated July 24, 2026
Guardant Health, Inc. logo
Ticker
A2N5RY:LSX
Asset type
Stock
Market cap
$19.54B
Sector
Health Technology
Industry
Medical Specialties
Exchange
LSX
Currency
EUR

Guardant Health, Inc. A2N5RY:LSX stock context

A2N5RY:LSX represents Guardant Health, Inc., a company focused on precision oncology through its innovative blood tests for cancer detection and treatment monitoring. Recently, Guardant Health has been involved in advancing its product offerings and expanding its market presence, with updates on clinical trials and partnerships that enhance its position in the healthcare sector. Investors can find relevant news, regulatory filings, and upcoming events that may impact the company's performance and strategic direction. The overall market context reflects a growing interest in cancer diagnostics and personalized medicine, which could influence Guardant Health's future growth.

Research Guardant Health, Inc.

Alternate listings